David Churchill

David has over 25 years of experience in the Canadian pharmaceutical and medical device industry. He has held a variety of sales and marketing roles, demonstrating a deep understanding of healthcare provider (HCP) drivers /decision-making triggers. His expertise extends to audience segmentation and the development of strategies and high impact tactics that effectively target each segment. David leads advisory boards, develops brand plans for existing and launch products, as well as serves as a board member of the Canadian Healthcare Communication Providers (CHCP). David's leadership roles prior to his current one at Lemieux Bédard include serving as a Marketing Manager and Business Unit Team Lead at Amgen, where he was instrumental in the success of products such as Aranesp, Sensipar, Neupogen, Neulasta, and the Victory Program. He also held the position of Director of Marketing for Chronic Renal Therapies at Baxter Canada.